860638P
Avanti
C18 Glucosyl(β) Ceramide-d5
Avanti Polar Lipids 860638P, powder
Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
D-glucosyl-β-1,1′-N-stearoyl-D-erythro-sphingosine-d5
Empirical Formula (Hill Notation):
C42H76D5NO8
Recommended Products
form
powder
packaging
pkg of 1 × 1 mg (860638P-1mg)
manufacturer/tradename
Avanti Polar Lipids 860638P
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@](/C=C/CCCCCCCCCCCC([2H])(C([2H])([2H])[2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
Application
C18 Glucosyl(β) Ceramide-d5 has been used as an internal standard for the quantification of glucosylceramide, in the extracts from mouse cerebellum by liquid chromatography-tandem mass spectrometry.
Packaging
5 mL Amber Glass Screw Cap Vial (860638P-1mg)
also commonly purchased with this product
Product No.
Description
Pricing
WGK
WGK 3
Flash Point(F)
No data available
Flash Point(C)
No data available
Regulatory Information
美国出口管控1C298产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Victoria Schiffer et al.
PloS one, 15(1), e0227077-e0227077 (2020-01-14)
Gaucher disease is caused by a deficiency in glucocerebrosidase that can result in non-neuronal as well as neuronal symptoms. Common visceral symptoms are an increased organ size, specifically of the spleen, and glucosylceramide as well as glucosylsphingosine substrate accumulations as
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service